docetaxel anhydrous has been researched along with 20-alpha-dihydroprogesterone in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (20-alpha-dihydroprogesterone) | Trials (20-alpha-dihydroprogesterone) | Recent Studies (post-2010) (20-alpha-dihydroprogesterone) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 534 | 4 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, R; Camozzi, F; Carozzi, V; Cavaletti, G; Cervellini, I; Crippa, D; Lauria, G; Melcangi, RC; Roglio, I | 1 |
1 other study(ies) available for docetaxel anhydrous and 20-alpha-dihydroprogesterone
| Article | Year |
|---|---|
Docetaxel-induced peripheral neuropathy: protective effects of dihydroprogesterone and progesterone in an experimental model.
Topics: 20-alpha-Dihydroprogesterone; Analysis of Variance; Animals; Body Weight; Disease Models, Animal; Docetaxel; Gene Expression Regulation; Male; Myelin Basic Protein; Myelin P0 Protein; Myelin Proteins; Nerve Fibers; Neural Conduction; Neuroprotective Agents; Pain Threshold; Peripheral Nervous System Diseases; Progesterone; Rats; Rats, Inbred F344; Sciatic Nerve; Taxoids | 2009 |